IL4 and COVID-19: IL-4 inhibits neutrophil effector functions by restricting expansion and attenuating migration into tissues via downregulation of CXCR2 (28), which was significantly downregulated (P = 5.00 × 10–25) in the neutrophils of aged patients with COVID-19 in our data set.